Nitazoxanide is active against Mycobacterium leprae-Reference-Cited by-同舟云学术

Nitazoxanide is active against Mycobacterium leprae

Published:2017-08-29 Issue:8 Volume:12 Page:e0184107
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bailey Mai Ann,Na Hana,Duthie Malcolm S.,Gillis Thomas P.,Lahiri Ramanuj,Parish Tanya^ORCID

Funder

New York Community Trust Heiser Foundation

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference53 articles.

1. Fixed-duration therapy in leprosy: limitations and opportunities;M Malathi;Indian J Dermatol,2013

2. What stops people completing multi-drug therapy? Ranked perspectives of people with leprosy, their head of family and neighbours—across four Indian states;MS Raju;Lepr Rev,2015

3. Noncompliance with the world health organization-multidrug therapy among leprosy patients in Cebu, Philippines: its causes and implications on the leprosy control program;ER Honrado;Dermatol Clin,2008

4. Rapid bactericidal effect of rifampin on Mycobacterium leprae;CC Shepard;Am J Trop Med Hyg,1972

5. Further experience with the rapid bactericidal effect of rifampin on Mycobacterium leprae;CC Shepard;Am J Trop Med Hyg,1974

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological efficacy and potential of the use of nitazoxanide, a thiazolide drug with a wide spectrum of action;Reviews on Clinical Pharmacology and Drug Therapy;2024-04-27

2. The pipeline for drugs for control and elimination of neglected tropical diseases: 2. Oral anti-infective drugs and drug combinations for off-label use;Parasites & Vectors;2023-10-31

3. The Many Hosts of Mycobacteria 9 (MHM9): A conference report;Tuberculosis;2023-09

4. Increscent journey of anti-leprosy drug development;CURR SCI INDIA;2023

5. Potential Repurposed Drug Candidates for Tuberculosis Treatment: Progress and Update of Drugs Identified in Over a Decade;ACS Omega;2023-05-10